StockNews.com started coverage on shares of Jaguar Health (NASDAQ:JAGX – Free Report) in a research note published on Monday. The firm issued a sell rating on the biotechnology company’s stock.
Jaguar Health Stock Performance
Shares of NASDAQ JAGX opened at $0.17 on Monday. The company has a 50 day simple moving average of $0.09 and a 200 day simple moving average of $0.18. Jaguar Health has a 1 year low of $0.05 and a 1 year high of $1.22. The company has a current ratio of 2.00, a quick ratio of 1.34 and a debt-to-equity ratio of 6.33.
About Jaguar Health
Featured Stories
- Five stocks we like better than Jaguar Health
- What is a Death Cross in Stocks?
- High-Yield Texas Instruments Could Hit New Highs Soon
- What is the Australian Securities Exchange (ASX)
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for Jaguar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Health and related companies with MarketBeat.com's FREE daily email newsletter.